Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability
Sònia Guedan(Fundació Clínic per a la Recerca Biomèdica), Avery D. Posey(Translational Therapeutics (United States))
Cited by 195
Related Papers
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
|JCI Insight|2018|573
Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
|Cancer Immunology Research|2015|332
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
|Frontiers in Immunology|2020|310
CD5 deletion enhances the antitumor activity of adoptive T cell therapies
|Science Immunology|2024|45